Global Pharmaceuticals & Biotech Profitable Climbers

Corcept Therapeutics

Market Cap: US$7.6b

A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Zevra Therapeutics

Market Cap: US$643.2m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Rubicon Research

Market Cap: ₹209.6b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

Camurus

Market Cap: SEK 30.6b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

PharmaEssentia

Market Cap: NT$334.1b

A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.

Neuren Pharmaceuticals

Market Cap: AU$1.7b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

Bonesupport Holding

Market Cap: SEK 14.1b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

Kuros Biosciences

Market Cap: CHF 738.8m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

Krystal Biotech

Market Cap: US$8.6b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

BioArctic

Market Cap: SEK 27.9b

Develops biological drugs for patients with central nervous system disorders in Sweden.

Wedge IndustrialLtd

Market Cap: CN¥14.9b

Engages in the research and development, production, and sale of micro-ecological live bacteria products, superalloys, and related products in China.

Acutaas Chemicals

Market Cap: ₹256.7b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

Royalty Pharma

Market Cap: US$31.1b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Alnylam Pharmaceuticals

Market Cap: US$38.2b

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.

Abeona Therapeutics

Market Cap: US$324.3m

A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)

Market Cap: ج.م10.1b

Engages in producing, marketing, selling, and storing pharmaceutical reagents for human and veterinary use.

Jiangxi Fushine Pharmaceutical

Market Cap: CN¥8.6b

Engages in the research, development, production, and sale of APIs and pharmaceutical intermediates in China and internationally.

Aether Industries

Market Cap: ₹151.2b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

XtalPi Holdings

Market Cap: HK$33.6b

Operates as a research platform company in Mainland China, the United States, and internationally.

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$42.3b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

Darwin

Market Cap: €72.0m

Operates in the healthcare industry.

Clinuvel Pharmaceuticals

Market Cap: AU$450.3m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Bide Pharmatech

Market Cap: CN¥4.2b

Engages in the research, development, production, and sale of pharmaceutical products in China.

Shanghai Haoyuan Chemexpress

Market Cap: CN¥16.2b

Researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs.

SKAN Group

Market Cap: CHF 1.1b

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.

Pharma Mar

Market Cap: €1.6b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.

Kiniksa Pharmaceuticals International

Market Cap: US$3.6b

A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.

May & Baker Nigeria

Market Cap: ₦82.8b

May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.

Bora Pharmaceuticals

Market Cap: NT$45.0b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

CORONA Remedies

Market Cap: ₹104.2b

A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.

SIGA Technologies

Market Cap: US$309.8m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Senores Pharmaceuticals

Market Cap: ₹48.1b

Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.

Genovis AB (publ.)

Market Cap: SEK 1.3b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

Labiana Health

Market Cap: €57.4m

Develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally.

Devyser Diagnostics

Market Cap: SEK 1.6b

Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.

Liquidia

Market Cap: US$4.9b

A biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States.